Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells
Authors:
- 1 January 1997
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 42 (1) , 73-81
Abstract
Recent studies have demonstrated that following estrogen ablation, estrogen responsive breast cancer cells undergo apoptosis. In addition, estrogen receptor (ER) expression has been strongly correlated with the expression of the bcl-2 gene product, p26Bcl-2 protein, which is known to inhibit apoptosis. In the present studies, we investigated whether estrogen affects the intracellular levels of p26Bcl-2 and thereby modulates taxol-induced apoptosis of estrogen responsive human breast cancer MCF-7 cells. Transfer of MCF-7 cells to a culture-medium without estrogens reduced their intracellular p26Bcl-2 levels by 50%. Inclusion of 0.1 μM estradiol in the medium produced approximately a four-fold increase in p26Bcl-2, but not p29Bcl-xL or p21Bax levels; the expression of the c-myc and mdr-1 genes remained unchanged. Estradiol-induced four-fold increase in the ratio of the p26Bcl-2 to p21Bax levels caused a significant decline in the lethal, kilobase size DNA fragments of apoptosis, which had resulted when MCF-7 cells were cultured in a medium without estrogen. In addition, in MCF-7 cells, estradiol-induced increase in the intracellular p26Bcl-2 to p21Bax ratios was associated with a significant reduction in the large-sized DNA fragmentation induced by treatment with taxol. The increased ratios also protected MCF-7 cells against taxol-mediated cytotoxicity as assessed by the MTT assay. These results suggest that by modulating p26Bcl-2 levels, estrogens may affect the antitumor activity of taxol and potentially of other anti-breast cancer drugs against estrogen responsive human breast cancer cells.Keywords
This publication has 17 references indexed in Scilit:
- bcl‐2 expression in normal breast tissue during the menstrual cycleInternational Journal of Cancer, 1994
- The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.Proceedings of the National Academy of Sciences, 1994
- Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced TranscriptionScience, 1994
- Reversal of Chemoresistance of Lymphoma Cells by Antisense-Mediated Reduction of bcl -2 Gene ExpressionAntisense Research and Development, 1994
- Bcl-2 and the regulation of programmed cell deathJournal of Cell Biology, 1994
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- An improved MIT assayJournal of Immunological Methods, 1993
- Apoptotic cell death induced by c-myc is inhibited by bcl-2Nature, 1992
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI: Journal of the National Cancer Institute, 1991